S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PCRX Pacira BioSciences Inc

20.55

0.00 (0.00%)

Pre Market

Last Updated: 20:00:00

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Pacira BioSciences Charts.

Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Pacira BioSciences Charts.

Pacira BioSciences Inc News

Form 8-K - Current report
Saturday 11 January 2025 (5 days ago) • Edgar (US Regulatory)

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
Saturday 11 January 2025 (5 days ago) • GlobeNewswire Inc.

Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block
Wednesday 8 January 2025 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 7 January 2025 (1 week ago) • Edgar (US Regulatory)

Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Friday 3 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 14 December 2024 (1 month ago) • Edgar (US Regulatory)

DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc.
Thursday 12 December 2024 (1 month ago) • PR Newswire (US)

More Pacira BioSciences Inc News Articles

AUD vs US Dollar

Commonwealth Bank Of Aus...

Woodside Petroleum

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions